Kernal Biologics Patents

Patent portfolio assigned to Kernal Biologics (verified via public assignee records). Estimated patent count: 2. Cambridge MA onco-selective mRNA therapeutics company. ARPA-H is a federal grant funder (up to $48M); joined Lilly Gateway Labs accelerator. As an early-stage therapeutics company it has no commercial customers. Assignee of at least 2 patents (WO2022140588A1, WO2020033720A1); count is a visible minimum, not exhaustive. No direct competitor confirmed from a company-owned page.